SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - PHARMACYTE BIOTECH INC ownership

Back to all holdings Add to watchlist

PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 32 filers reported holding PHARMACYTE BIOTECH INC in Q2 2022. The put-call ratio across all filers is 6.70 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of PHARMACYTE BIOTECH INC
ValueSharesWeighting
Q1 2022$80,000
-28.6%
34,805
-22.6%
0.00%
-33.3%
Q4 2021$112,000
-29.1%
44,944
-9.6%
0.00%0.0%
Q3 2021$158,000–49,700–0.00%–
 Download
Other shareholders
PHARMACYTE BIOTECH INC shareholders Q2 2022
NameSharesValueWeighting ↓
Ayrton Capital LLC 92,087$193,3831.31%
SABBY MANAGEMENT, LLC 97,124$203,9600.15%
K2 PRINCIPAL FUND, L.P. 258,481$542,8100.11%
EQUITEC PROPRIETARY MARKETS, LLC 82,727$173,7270.04%
CSS LLC/IL 13,186$27,6910.00%
Aspire Private Capital, LLC 800$1,6800.00%
Schonfeld Strategic Advisors LLC 23,300$48,9300.00%
OSAIC HOLDINGS, INC. 1,971$4,1390.00%
DIMENSIONAL FUND ADVISORS LP 29,307$61,5450.00%
BANK OF AMERICA CORP /DE/ 116$2430.00%
View complete list of PHARMACYTE BIOTECH INC shareholders